340 related articles for article (PubMed ID: 32758158)
1. Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda.
Eneh PC; Hullsiek KH; Kiiza D; Rhein J; Meya DB; Boulware DR; Nicol MR
BMC Infect Dis; 2020 Aug; 20(1):572. PubMed ID: 32758158
[TBL] [Abstract][Full Text] [Related]
2. Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals.
Feinstein J; Dai D; Zhong W; Freedman J; Feudtner C
Pediatrics; 2015 Jan; 135(1):e99-108. PubMed ID: 25511114
[TBL] [Abstract][Full Text] [Related]
3. [Cryptococcal meningitis in children: description of 3 cases].
Ndiaye M; Diagne NR; Seck LB; Sow AD; Sène MS; Diop AG; Sow HD; Ndiaye MM
Med Trop (Mars); 2011 Apr; 71(2):176-8. PubMed ID: 21695878
[TBL] [Abstract][Full Text] [Related]
4. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
[TBL] [Abstract][Full Text] [Related]
5. Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda.
Longley N; Muzoora C; Taseera K; Mwesigye J; Rwebembera J; Chakera A; Wall E; Andia I; Jaffar S; Harrison TS
Clin Infect Dis; 2008 Dec; 47(12):1556-61. PubMed ID: 18990067
[TBL] [Abstract][Full Text] [Related]
6. Potential drug-drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria.
Noor S; Ismail M; Khadim F
Malar J; 2020 Aug; 19(1):316. PubMed ID: 32867788
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in AIDS-related cryptococcal meningitis treatment with an emphasis on resource limited settings.
Lofgren S; Abassi M; Rhein J; Boulware DR
Expert Rev Anti Infect Ther; 2017 Apr; 15(4):331-340. PubMed ID: 28111998
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory features of cryptococcal meningitis in HIV-AIDS patients.
Deo S
J Assoc Physicians India; 1995 Oct; 43(10):724. PubMed ID: 8773019
[No Abstract] [Full Text] [Related]
9. 'Time-to-amphotericin B' in cryptococcal meningitis in a European low-prevalence setting: analysis of diagnostic delays.
Katchanov J; von Kleist M; Arastéh K; Stocker H
QJM; 2014 Oct; 107(10):799-803. PubMed ID: 24722846
[TBL] [Abstract][Full Text] [Related]
10. Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.
Smith KD; Achan B; Hullsiek KH; McDonald TR; Okagaki LH; Alhadab AA; Akampurira A; Rhein JR; Meya DB; Boulware DR; Nielsen K;
Antimicrob Agents Chemother; 2015 Dec; 59(12):7197-204. PubMed ID: 26324276
[TBL] [Abstract][Full Text] [Related]
11. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a national cryptococcal antigen screening program for HIV-infected patients in Uganda: A cost-effectiveness modeling analysis.
Rajasingham R; Meya DB; Greene GS; Jordan A; Nakawuka M; Chiller TM; Boulware DR; Larson BA
PLoS One; 2019; 14(1):e0210105. PubMed ID: 30629619
[TBL] [Abstract][Full Text] [Related]
13. Ambulatory induction phase treatment of cryptococcal meningitis in HIV integrated primary care clinics, Yangon, Myanmar.
Warrell CE; Macrae C; McLean ARD; Wilkins E; Ashley EA; Smithuis F; Tun NN
BMC Infect Dis; 2021 Apr; 21(1):375. PubMed ID: 33882845
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy: a case report.
Otto SBJ; George PE; Mercedes R; Nabukeera-Barungi N
BMC Infect Dis; 2020 Jan; 20(1):68. PubMed ID: 31964348
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging of HIV-associated cryptococcal meningitis: comparison of magnetic resonance imaging findings in patients with and without immune reconstitution.
Katchanov J; Branding G; Jefferys L; Arastéh K; Stocker H; Siebert E
Int J STD AIDS; 2016 Feb; 27(2):110-7. PubMed ID: 25693580
[TBL] [Abstract][Full Text] [Related]
16. Analysis of potential drug-drug interactions in medical intensive care unit patients.
Uijtendaal EV; van Harssel LL; Hugenholtz GW; Kuck EM; Zwart-van Rijkom JE; Cremer OL; Egberts TC
Pharmacotherapy; 2014 Mar; 34(3):213-9. PubMed ID: 24390929
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.
Sloan D; Dlamini S; Paul N; Dedicoat M
Cochrane Database Syst Rev; 2008 Oct; (4):CD005647. PubMed ID: 18843697
[TBL] [Abstract][Full Text] [Related]
18. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
Maher D; Mwandumba H
J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
[TBL] [Abstract][Full Text] [Related]
19. Cryptoccocal meningitis in Yaoundé (Cameroon) HIV infected patients: Diagnosis, frequency and Cryptococcus neoformans isolates susceptibility study to fluconazole.
Kammalac Ngouana T; Dongtsa J; Kouanfack C; Tonfack C; Fomena S; Mallié M; Delaporte E; Boyom FF; Bertout S
J Mycol Med; 2015 Mar; 25(1):11-6. PubMed ID: 25467817
[TBL] [Abstract][Full Text] [Related]
20. Potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan.
Ismail M; Khan F; Noor S; Haider I; Haq IU; Ali Z; Shah Z; Hassam M
Int J Clin Pharm; 2016 Oct; 38(5):1052-6. PubMed ID: 27365090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
